Go to deals
Private Equity | Healthcare

Metrigraphics has been acquired by Cirtec Medical Corp.

Metrigraphics, a portfolio company of New England Capital Partners and Clarkston Merchant Partners, has been sold to Cirtec Medical, a portfolio company of 3i Group plc (LSE:III).

Metrigraphics is a leading manufacturer of ultra-high precision, custom micron-scale medical device components for growing markets including continuous glucose monitoring, advanced drug delivery, active medication management and life science instruments.

Cirtec Medical engages in the outsourced design, engineering, development and manufacturing of class II and III medical devices. The company develops product platforms for neuromodulation, implantable drug delivery, cardiac rhythm management, ventricular assist devices and minimally invasive surgical systems. It also provides product development services ranging from concept to commercialization, which include program management, design and development, clinical build and regulatory support, and assembly and manufacturing, as well as flexible product transfer programs to allow relocation or duplication of product manufacturing lines to help expand manufacturing capacity, optimize yields and reserve capital. The company serves medical device companies that range from large manufacturers to small startups around the world.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Metrigraphics in this transaction.

Service
M&A sell-side
Parties

Talk to the deal team

 Michael S. Goldman

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital
 Kevin  Atchue

Kevin Atchue

Principal

Boston, United States
Oaklins TM Capital
 Craig M. Gibson

Craig M. Gibson

Managing Director

Boston, United States
Oaklins TM Capital
 James  McLaren

James McLaren

Managing Director

New York, United States
Oaklins TM Capital

Related deals

Groupe Nature acquires Winco
Consumer & Retail | Healthcare

Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Learn more
Camelia pharmacy chain has been acquired by Medigate Management UAB
Consumer & Retail | Healthcare

Camelia pharmacy chain has been acquired by Medigate Management UAB

CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.

Learn more
Shield Therapeutics has raised funds
Healthcare

Shield Therapeutics has raised funds

Shield Therapeutics Plc has completed a placing, subscription and open offer. The primary use of the funds is to launch Accrufer® in the USA.

Learn more